Bank of Japan won’t raise rates when markets unstable, deputy governor says

Bank of Japan won’t raise rates when markets unstable, deputy governor says


The Japanese flag flutters over the Bank of Japan (BoJ) head office building (bottom) in Tokyo on April 27, 2022.

Kazuhiro Nogi | Afp | Getty Images

Bank of Japan Deputy Governor Shinichi Uchida said on Wednesday the central bank won’t raise interest rates when financial markets are unstable.

The recent strengthening of the yen would affect the BOJ’s policy decision because it reduces upward pressure on import prices, and therefore overall inflation, Uchida said.

Stock market volatility would also influence the central bank’s decision by affecting corporate activity and consumption, he said.

Analyst explains what's behind the BOJ's decision to hike rates

“As we’re seeing sharp volatility in domestic and overseas financial markets, it’s necessary to maintain current levels of monetary easing for the time being,” Uchida said in a speech to business leaders in the northern Japan city of Hakodate.

The BOJ’s interest rate path will “obviously” change if market volatility affects its economic and price outlook, its view on risks, and the likelihood of durably achieving its 2% inflation target, he said.

“We won’t raise interest rates when financial markets are unstable,” Uchida said.



Source

Soho House to go private in .7 billion deal, Ashton Kutcher to join board
World

Soho House to go private in $2.7 billion deal, Ashton Kutcher to join board

Pavlo Gonchar | SOPA Images | Getty Images Soho House is going private in a $2.7 billion deal led by New York-based MCR Hotels, capping a turbulent market run and financial struggles that erased nearly half of the high-end members club operator’s value since its 2021 debut. Its shareholders will get $9 per share, a […]

Read More
Investors looking beyond the U.S. see opportunities in one small pocket of Europe
World

Investors looking beyond the U.S. see opportunities in one small pocket of Europe

European markets have seen a resurgence this year, with multiple regional indexes outperforming their Wall Street rivals. Amid a broad push to diversify portfolios away from the U.S., some traders see an “unmatched advantage” and “really good investment opportunities” in particular area of Europe. Earlier this year, volatility arising from U.S. President Donald Trump’s unpredictable […]

Read More
Eli Lilly’s 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump’s pricing pressures
World

Eli Lilly’s 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump’s pricing pressures

Key Points Pharma giants are navigating U.S. President Donald Trump’s demands to bring U.S. drug prices in line with other developed nations. Eli Lilly’s decision to hike Mounjaro prices in the U.K. could spark similar moves from other firms, analysts say. The U.S. consistently pays the most in the world for many prescription drugs. Eli Lilly ‘s […]

Read More